Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Sci Robot ; 6(52)2021 03 31.
Article in English | MEDLINE | ID: covidwho-1209822

ABSTRACT

The world was unprepared for the COVID-19 pandemic, and recovery is likely to be a long process. Robots have long been heralded to take on dangerous, dull, and dirty jobs, often in environments that are unsuitable for humans. Could robots be used to fight future pandemics? We review the fundamental requirements for robotics for infectious disease management and outline how robotic technologies can be used in different scenarios, including disease prevention and monitoring, clinical care, laboratory automation, logistics, and maintenance of socioeconomic activities. We also address some of the open challenges for developing advanced robots that are application oriented, reliable, safe, and rapidly deployable when needed. Last, we look at the ethical use of robots and call for globally sustained efforts in order for robots to be ready for future outbreaks.


Subject(s)
Communicable Disease Control/trends , Communicable Diseases , Robotics/trends , COVID-19/prevention & control , Communicable Diseases/diagnosis , Communicable Diseases/therapy , Disinfection/trends , Humans , Machine Learning , Pandemics/prevention & control , Remote Sensing Technology/trends , Robotic Surgical Procedures/trends , Robotics/instrumentation , SARS-CoV-2 , User-Computer Interface
2.
Int J Cardiol ; 328: 247-249, 2021 04 01.
Article in English | MEDLINE | ID: covidwho-957115

ABSTRACT

BACKGROUND: Remote monitoring (RM) technology embedded in cardiac rhythm devices permits continuous monitoring of device function, and recording of selected cardiac physiological parameters and cardiac arrhythmias and may be of utmost utility during Coronavirus (COVID-19) pandemic, when in-person office visit for regular follow-up were postponed. However, patients not alredy followed-up via RM represent a challenging group of patients to be managed during the lockdown. METHODS: We reviewed patient files scheduled for an outpatient visit between January 1, 2020 and May 11th, 2020 to assess the proportion of patients in whom RM activation was possible without office visit, and compared them to those scheduled for visit before the lockdown. RESULTS: During COVID-19 pandemic, RM activation was feasible in a minority of patients (7.8% of patients) expected at outpatient clinic for a follow-up visit and device check-up. This was possible in a good proportion of complex implantable devices such as cardiac resynchronization therapy and implantable cardioverter defibrillator but only in a minority of patients with a pacemaker the RM function could be activated during the period of restricted access to hospital. CONCLUSIONS: Our experience strongly suggest to consider the systematic activation of RM function at the time of implantation or - by default programming - in all cardiac rhythm management devices.


Subject(s)
Arrhythmias, Cardiac/therapy , COVID-19/prevention & control , Cardiac Resynchronization Therapy Devices/standards , Defibrillators, Implantable/standards , Remote Sensing Technology/standards , Aged , Arrhythmias, Cardiac/diagnosis , Arrhythmias, Cardiac/epidemiology , COVID-19/epidemiology , Cardiac Resynchronization Therapy Devices/trends , Communicable Disease Control/standards , Communicable Disease Control/trends , Defibrillators, Implantable/trends , Female , Follow-Up Studies , Humans , Male , Pandemics/prevention & control , Remote Sensing Technology/trends
4.
Policy Polit Nurs Pract ; 21(4): 195-201, 2020 Nov.
Article in English | MEDLINE | ID: covidwho-694369

ABSTRACT

The 21st Century Cures Act, passed in December 2016 by the United States Congress, is a public law aimed at accelerating the time it takes to get pharmaceutical drugs and medical devices into the market, in addition to shifting connected review processes from randomized controlled trials to real-world efficacy tests. As of December 2019, efforts are underway to introduce a "Cures Act 2.0" bill, with particular attention to the implementation of digital health within health systems. Research on the development of emergent health technologies is nascent; research examining health technology implications of 21st Century Cures Act for the health care workforce is nonexistent. This article fills a crucial gap in public awareness, discussing ethical implications of the 21st Century Cures Act and centering nursing. Nursing is a profession frequently acknowledged as practicing on "the front lines of care" and frequently responsible for the trialing of products in clinical settings. The article summarizes and evaluates key components of the 21st Century Cures Act related to health technology development. Discrete health technologies addressed are (a) breakthrough devices, (b) digital health software, and (c) combination products. It then connects these provisions to ethical considerations for nursing practice, research, and policy. The article concludes by discussing the relevance of emerging digital health technologies to the crafting of a "Cures 2.0" bill, with particular attention to this moment in light of digital care precedents set during the COVID-19 pandemic.


Subject(s)
Biomedical Technology/ethics , Coronavirus Infections/epidemiology , Pneumonia, Viral/epidemiology , Remote Sensing Technology/ethics , Betacoronavirus , Biomedical Technology/trends , COVID-19 , Coronavirus Infections/therapy , Critical Care/ethics , Forecasting , Humans , Pandemics , Pneumonia, Viral/therapy , Remote Sensing Technology/trends , SARS-CoV-2 , United States
SELECTION OF CITATIONS
SEARCH DETAIL